Published in J Biomed Mater Res A on November 01, 2003
Bioactive glass scaffolds for bone tissue engineering: state of the art and future perspectives. Mater Sci Eng C Mater Biol Appl (2011) 1.18
An improved mechanical testing method to assess bone-implant anchorage. J Vis Exp (2014) 0.75
In vitro behaviour of three biocompatible glasses in composite implants. J Mater Sci Mater Med (2012) 0.75
The incidence of osteopenia and osteoporosis in women with hip osteoarthritis scheduled for cementless total joint replacement. Bone (2007) 1.70
Recombinant human bone morphogenetic protein-2 in open tibial fractures. A subgroup analysis of data combined from two prospective randomized studies. J Bone Joint Surg Am (2006) 1.48
Radiostereometric analysis in measurements of migration and inducible micromotion in intra-articular distal radius fractures treated with a volar plate. J Orthop Trauma (2012) 1.41
Female patients with low systemic BMD are prone to bone loss in Gruen zone 7 after cementless total hip arthroplasty. Acta Orthop (2009) 1.27
Circulating plastic adherent mesenchymal stem cells in aged hip fracture patients. J Orthop Res (2010) 1.16
MicroRNAs miR-96, miR-124, and miR-199a regulate gene expression in human bone marrow-derived mesenchymal stem cells. J Cell Biochem (2012) 1.14
High tibial osteotomy for the treatment of osteoarthritis of the knee: a review of the literature and a meta-analysis of follow-up studies. Arch Orthop Trauma Surg (2003) 1.09
Antibacterial effect of bioactive glasses on clinically important anaerobic bacteria in vitro. J Mater Sci Mater Med (2007) 1.05
Precision measurements of the RSA method using a phantom model of hip prosthesis. J Biomech (2004) 1.03
Comparative 18F-FDG PET of experimental Staphylococcus aureus osteomyelitis and normal bone healing. J Nucl Med (2004) 1.01
Comparison of 18F-FDG and 68Ga PET imaging in the assessment of experimental osteomyelitis due to Staphylococcus aureus. Eur J Nucl Med Mol Imaging (2005) 1.00
In vitro and in vivo release of ciprofloxacin from osteoconductive bone defect filler. J Antimicrob Chemother (2005) 0.97
Efficacy of ciprofloxacin-releasing bioabsorbable osteoconductive bone defect filler for treatment of experimental osteomyelitis due to Staphylococcus aureus. Antimicrob Agents Chemother (2005) 0.96
A comparative 18F-FDG PET/CT imaging of experimental Staphylococcus aureus osteomyelitis and Staphylococcus epidermidis foreign-body-associated infection in the rabbit tibia. EJNMMI Res (2012) 0.95
No improvement in the overall survival of 194 patients with chondrosarcoma in Finland in 1971-1990. Acta Orthop Scand (2003) 0.94
Accuracy and precision of radiostereometric analysis in the measurement of three-dimensional micromotion in a fracture model of the distal radius. J Orthop Res (2005) 0.94
Transient 100 nM dexamethasone treatment reduces inter- and intraindividual variations in osteoblastic differentiation of bone marrow-derived human mesenchymal stem cells. Tissue Eng Part C Methods (2012) 0.91
(68)Ga-DOTAVAP-P1 PET imaging capable of demonstrating the phase of inflammation in healing bones and the progress of infection in osteomyelitic bones. Eur J Nucl Med Mol Imaging (2007) 0.89
Sustained release of ciprofloxacin from an osteoconductive poly(DL)-lactide implant. Acta Orthop (2008) 0.89
Molecular profiling of human chondrosarcomas for matrix production and cancer markers. Int J Cancer (2002) 0.89
In vitro and in vivo testing of bioabsorbable antibiotic containing bone filler for osteomyelitis treatment. J Biomed Mater Res A (2006) 0.87
Antibacterial effects and dissolution behavior of six bioactive glasses. J Biomed Mater Res A (2010) 0.87
Polysaccharide-coated thermosets for orthopedic applications: from material characterization to in vivo tests. Biomacromolecules (2012) 0.86
Comparison of the osteogenic capacity of minipig and human bone marrow-derived mesenchymal stem cells. J Orthop Res (2012) 0.86
Quality of intertrochanteric cancellous bone as predictor of femoral stem RSA migration in cementless total hip arthroplasty. J Biomech (2010) 0.86
In situ pH within particle beds of bioactive glasses. Acta Biomater (2008) 0.84
Instrumented spondylodesis in degenerative spondylolisthesis with bioactive glass and autologous bone: a prospective 11-year follow-up. J Spinal Disord Tech (2011) 0.84
Biologic tendon fixation to metallic implant augmented with autogenous cancellous bone graft and bone marrow in a canine model. J Orthop Res (2002) 0.83
A controlled register-based study of 460 neurofibromatosis 1 patients: increased fracture risk in children and adults over 41 years of age. J Bone Miner Res (2012) 0.82
Effect of zoledronic acid on incorporation of a bioceramic bone graft substitute. Bone (2005) 0.82
Molecular biological evaluation of bioactive glass microspheres and adjunct bone morphogenetic protein 2 gene transfer in the enhancement of new bone formation. Tissue Eng (2005) 0.81
30 years of bone banking at Turku bone bank. Cell Tissue Bank (2003) 0.80
Radio-opaque bioactive glass markers for radiostereometric analysis. Acta Biomater (2009) 0.79
In Vivo and In Vitro Study of a Polylactide-Fiber-Reinforced β-Tricalcium Phosphate Composite Cage in an Ovine Anterior Cervical Intercorporal Fusion Model. Int J Biomater (2011) 0.79
In vivo testing of a biodegradable woven fabric made of bioactive glass fibers and PLGA80--a pilot study in the rabbit. J Biomed Mater Res B Appl Biomater (2010) 0.79
Measuring the concentration of carboxylic acid groups in torrefied spruce wood. Bioresour Technol (2012) 0.78
Osteoclasts derived from patients with neurofibromatosis 1 (NF1) display insensitivity to bisphosphonates in vitro. Bone (2011) 0.77
Peripheral quantitative computed tomography in evaluation of bioactive glass incorporation with bone. Biomaterials (2005) 0.76
Adherence of hip and knee arthroplasty studies to RSA standardization guidelines. A systematic review. Acta Orthop (2014) 0.76
Three-dimensional computer simulation of radiostereometric analysis (RSA) in distal radius fractures. J Biomech (2006) 0.76
Mechanical verification of soft-tissue attachment on bioactive glasses and titanium implants. Acta Biomater (2008) 0.76
Pyrolysis of softwood carbohydrates in a fluidized bed reactor. Int J Mol Sci (2008) 0.75
Influence of pressure on pyrolysis of black liquor: 1. Swelling. Bioresour Technol (2007) 0.75
Bioactive glass microspheres as osteopromotive inlays in macrotextured surfaces of Ti and CoCr alloy bone implants: trapezoidal surface grooves without inlay most efficient in resisting torsional forces. J Mech Behav Biomed Mater (2011) 0.75
Quantitative characterization of porous commercial and experimental bone graft substitutes with microcomputed tomography. J Biomed Mater Res B Appl Biomater (2013) 0.75
Influence of pressure on pyrolysis of black liquor: 2. Char yields and component release. Bioresour Technol (2007) 0.75
Characterization of porous glass fiber-reinforced composite (FRC) implant structures: porosity and mechanical properties. J Mater Sci Mater Med (2013) 0.75
In vitro behaviour of three biocompatible glasses in composite implants. J Mater Sci Mater Med (2012) 0.75
Bioceramic inlays do not improve mechanical incorporation of grit-blasted titanium stems in the proximal sheep femur. J Biomed Mater Res A (2010) 0.75
The presence of zinc in Swedish waste fuels. Waste Manag (2013) 0.75
Hope for fragile patients with broken bones. Scand J Surg (2006) 0.75
Determination of fossil carbon content in Swedish waste fuel by four different methods. Waste Manag Res (2013) 0.75
Comparing the greenhouse gas emissions from three alternative waste combustion concepts. Waste Manag (2011) 0.75